APA

Meyers F. J., Cardiff R. D., Quadro R., Gribble M., Kohler M., Medrano V., Mitchell E. P., Shiffman R. & William L. (19860918). Epirubicin in non-oat cell lung cancer--response rates and the importance of immunopathology: a Northern California Oncology Group Study. : Cancer treatment reports.

Chicago

Meyers F J, Cardiff R D, Quadro R, Gribble M, Kohler M, Medrano V, Mitchell E P, Shiffman R and William L. 19860918. Epirubicin in non-oat cell lung cancer--response rates and the importance of immunopathology: a Northern California Oncology Group Study. : Cancer treatment reports.

Harvard

Meyers F. J., Cardiff R. D., Quadro R., Gribble M., Kohler M., Medrano V., Mitchell E. P., Shiffman R. and William L. (19860918). Epirubicin in non-oat cell lung cancer--response rates and the importance of immunopathology: a Northern California Oncology Group Study. : Cancer treatment reports.

MLA

Meyers F J, Cardiff R D, Quadro R, Gribble M, Kohler M, Medrano V, Mitchell E P, Shiffman R and William L. Epirubicin in non-oat cell lung cancer--response rates and the importance of immunopathology: a Northern California Oncology Group Study. : Cancer treatment reports. 19860918.